Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Persimmon Share Price
  4. Persimmon Share Regulatory News
  5. Dechra Pharmaceuticals

Pin to quick picksPersimmon Regulatory News (PSN)

Persimmon Information

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,424.50
Bid: 1,428.50
Ask: 1,430.00
Change: 18.00 (1.28%)
Spread: 1.50 (0.105%)
Open: 1,419.00
High: 1,440.00
Low: 1,418.50
Prev. Close: 1,406.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dechra Pharmaceuticals

11 Jan 2024 18:00

RNS Number : 4516Z
FTSE Russell
11 January 2024

Further to the FTSE notice released on 09 January 2024 in relation to Dechra Pharmaceuticals (UK): Constituent Deletion, please note the replacement in the fixed indices.

All other details remain unchanged. Please see updated notice below:

Dechra Pharmaceuticals (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

11 January 2024

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

Dechra Pharmaceuticals (UK, 0963318) will be deleted from the index.

Persimmon PLC (UK, 0682538) will be added to the FTSE 100 Index and deleted from the FTSE 250 Index.

Baillie Gifford US Growth Trust (UK, BDFGHW4) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

All changes effective from 16 January 2024

Full details of index changes are available on the FTSE Russell website.

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

Alternatively please visit our website at lseg.com/ftse-russell

Terms of Use | Copyright © 2024 FTSE Russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FTSFLFLDLIILLIS
12345678910
Date   Source Headline
28th Apr 20217:00 amRNSTrading Update
1st Apr 20213:52 pmRNSTotal Voting Rights
26th Mar 20211:20 pmRNSAnnual Report 2020 and Notice of AGM 2021
23rd Mar 20213:27 pmRNSDirector/PDMR Shareholding
23rd Mar 202111:09 amRNSDirector Declaration
22nd Mar 202111:01 amRNSDirector/PDMR Shareholding
8th Mar 20211:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSFinal Results
1st Mar 20213:52 pmRNSTotal Voting Rights
10th Feb 20217:00 amRNSPersimmon Acts to Address Legacy Cladding Issues
1st Feb 20212:19 pmRNSTotal Voting Rights
13th Jan 20217:00 amRNSTrading Statement
4th Jan 20213:10 pmRNSTotal Voting Rights
17th Dec 20201:12 pmRNSAppointment of Independent Non-Executive Director
15th Dec 20207:00 amRNSComposition of Remuneration Committee
8th Dec 20203:50 pmRNSDirector/PDMR Shareholding
1st Dec 20203:22 pmRNSBlock listing Interim Review
1st Dec 20203:01 pmRNSTotal Voting Rights
25th Nov 202011:50 amRNSAdditional Listing
10th Nov 20207:00 amRNSThird Quarter Trading Statement
2nd Nov 20203:11 pmRNSTotal Voting Rights
27th Oct 20203:37 pmRNSAdditional Listing
16th Oct 202012:46 pmRNSGrant of SAYE Option
29th Sep 202012:27 pmRNSDirector/PDMR Shareholding
8th Sep 202010:25 amRNSNew Chief Executive Officer Start Date
1st Sep 20202:00 pmRNSTotal Voting Rights
28th Aug 20202:02 pmRNSDirector/PDMR Shareholding
26th Aug 20207:44 amRNSPersimmon Plc (PSN) - Additional Listing
19th Aug 20207:02 amRNSUpdate on Chief Executive Officer Appointment
18th Aug 20207:00 amRNSHalf Year Results
20th Jul 20201:49 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSTrading Update
1st Jul 202012:42 pmRNSTotal Voting Rights
29th Jun 20204:58 pmRNSAppointment of CEO
24th Jun 20207:00 amRNSAppointment of new Chief Executive Officer
8th Jun 20204:17 pmRNSDirectorate Change
5th Jun 202010:00 amRNSDirector/PDMR Shareholding
1st Jun 20202:05 pmRNSBlock listing Interim Review
1st Jun 20201:13 pmRNSTotal Voting Rights
26th May 20202:28 pmRNSDirector/PDMR Shareholding
20th May 20208:40 amRNSDirector Declaration
14th May 20207:00 amRNSCOVID-19 Update
1st May 20201:56 pmRNSTotal Voting Rights
29th Apr 20203:34 pmRNSResult of AGM
29th Apr 20207:01 amRNSBoard Change
29th Apr 20207:00 amRNSTrading Update
27th Apr 20204:32 pmRNSDisclosure of rights attached to equity shares
24th Apr 20207:00 amRNSCOVID-19 Update
3rd Apr 20209:16 amRNSDirector Declaration
2nd Apr 20206:14 pmRNSFurther Update on Covid-19 – Board Remuneration
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.